E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Iowa
About this trial
The goal of this clinical trial is to test whether a web-based application called the Pain Control Enhancement App (PACE-app) can support family caregivers in managing pain for their care recipients with dementia. The main questions it aims to answer are:
Is it feasible and acceptable for family caregivers to use the PACE-app?
Does using the PACE-app improve caregiver self-efficacy in pain management, adherence to pain treatments, communication with care providers, well-being, and their care recipient's pain conditions?
Researchers will compare caregivers who use the PACE-app to those who continue with their usual care practices to see if the app leads to better outcomes for both caregivers and care recipients.
Participants will:
Be randomly assigned to either the PACE-app group or a usual-care control group
Complete online surveys at baseline, 1 month, and 2 months
If assigned to the PACE-app group:
Use the PACE-app for 1 month to receive tailored pain management strategies and tools, and record their care recipient's pain in a digital diary
Participate in an interview about their experience with the app
All participation activities can be done remotely or in person.
Eligibility criteria
Qualifiers
Be a primary caregiver - (a family member, relative, or friend) of a person with dementia (or cognitive impairment) and chronic pain (lasting >3 months)'
Be responsible for managing the care recipient's pain and pain treatments (including interpreting verbal or non-verbal pain communication).
Be age 18 - 100.
Be able to read and speak English.
Disqualifiers
Currently participating in another research study that could interfere with this intervention.
Trial design
Treatments tested in this trial
- Web-based pain management support tool
- Usual Pain Management Care
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Iowa
Lead sponsor
Alzheimer's Association
Collaborator
Source ClinicalTrials.gov